Lipantil Supra 145mg film-coated tablets

Country: Ireland

Language: English

Source: HPRA (Health Products Regulatory Authority)

Buy It Now

Active ingredient:

Fenofibrate

Available from:

LTT Pharma Limited

ATC code:

C10AB; C10AB05

INN (International Name):

Fenofibrate

Dosage:

145 milligram(s)

Pharmaceutical form:

Film-coated tablet

Prescription type:

Product subject to prescription which may be renewed (B)

Therapeutic area:

Fibrates; fenofibrate

Authorization status:

Authorised

Authorization date:

2014-09-19

Patient Information leaflet

                                PACKAGE LEAFLET: INFORMATION FOR THE USER
LIPANTIL SUPRA 145MG FILM-COATED TABLETS
(fenofibrate)
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE
BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU.
*
Keep this leaflet. You may need to read it again.
*
If you have any further questions, ask your doctor, or pharmacist.
*
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them even if their signs of illness are the same
as
yours.
*
If you get any side effects, talk to your doctor, or pharmacist or
nurse.
Thisincludes any possible side effects not listed in this leaflet.
WHAT IS IN THIS LEAFLET:
What Lipantil Supra is and what it is used for
What you need to know before you take Lipantil Supra
How to take Lipantil Supra
Possible side effects
How to store Lipantil Supra
Contents of the pack and other information
WHAT LIPANTIL SUPRA IS AND WHAT IT IS USED FOR
Lipantil Supra belongs to a group of medicines, commonly known as
fibrates. These medicines are used to lower the level of fats (lipids)
in the
blood. For example the fats known as triglycerides.
Lipantil Supra is used, alongside a low fat diet and other non-medical
treatments such as exercise and weight loss, to lower levels of fats
in the
blood.
Lipantil Supra can be used in addition to other medicines (statins) in
some
circumstances when levels of fats in the blood are not controlled with
a statin
alone.
WHAT YOU NEED TO KNOW BEFORE YOU TAKE LIPANTIL
SUPRA
DO NOT TAKE LIPANTIL SUPRA IF:
*
you are allergic to fenofibrate or any of the other ingredients of
this
medicine (listed in Section 6, Contents of the pack and other other
information)
*
you are allergic to peanut, arachis oil, soya lecithin or related
products
*
while taking other medicines (such as other fibrates or an
anti-inflammatory medicine called ‘ketoprofen’),
*
you have had an allergic reaction or skin damage from sunlight or UV
light
*
you have severe liver, kidney or gallbladder problems
*
you have pancreatitis (an inflamed pancreas
                                
                                Read the complete document
                                
                            

Summary of Product characteristics

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Lipantil Supra 145mg film-coated tablets
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 145.0 mg fenofibrate (nanoparticles).
Excipients with known effect: each tablet contains:
-
Lactose monohydrate
-
Sucrose
-
Soybean lecithin.
For the full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Film coated tablet.
_Product imported from France_
White, oblong, film-coated tablets engraved “145” on one side and
“Fournier logo” on the other side.
4 CLINICAL PARTICULARS
As per PA2010/015/003
5 PHARMACOLOGICAL PROPERTIES
As per PA2010/015/003
6 PHARMACEUTICAL PARTICULARS
6.1 LIST OF EXCIPIENTS
Core:
Sucrose
Lactose monohydrate
Microcrystalline cellulose and colloidal anhydrous silica
Crospovidone
Hypromellose
Sodium lauril sulfate
Docusate sodium
Magnesium stearate
Coating:
Polyvinyl alcohol
Titanium dioxide (E171)
Talc
Soybean lecithin
Xanthan gum.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_0_
_9_
_/_
_0_
_4_
_/_
_2_
_0_
_1_
_8_
_C_
_R_
_N_
_ _
_2_
_2_
_0_
_4_
_2_
_0_
_9_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
6.2 INCOMPATIBILITIES
Not applicable.
6.3 SHELF LIFE
The shelf life expiry date of this product shall be the date shown on
the container and outer package of the product on
the market in the country of origin.
6.4 SPECIAL PRECAUTIONS FOR STORAGE
Do not store above 30°C
Store in the original packaging.
6.5 NATURE AND CONTENTS OF CONTAINER
Thermoformed blister s
                                
                                Read the complete document
                                
                            

Search alerts related to this product